ClinConnect ClinConnect Logo
Search / Trial NCT04926597

Effect of Continued Nutritional Support at Hospital Discharge on Mortality, Frailty, Functional Outcomes and Recovery

Launched by PHILIPP SCHUETZ · Jun 8, 2021

Trial Information

Current as of October 03, 2025

Recruiting

Keywords

Nutritional Support Oral Nutritional Supplements Frailty Mortality Morbidity

ClinConnect Summary

This clinical trial is investigating whether continued nutritional support after leaving the hospital can help patients who are at risk of malnutrition. The goal is to see if providing personalized nutrition plans that meet each patient’s energy and protein needs leads to better health outcomes compared to the usual home nutrition care. This study is open to adults aged 18 and older who have been identified as being at nutritional risk, which includes factors like significant weight loss or having serious health conditions such as cancer or chronic heart failure.

To participate, you would need to give your consent and meet specific health criteria, such as being a medical patient with a certain level of nutritional risk. However, there are some exclusions, like those who have recently had surgery or are unable to eat normally. If you join the trial, you can expect to receive extra nutritional support after you leave the hospital, which may help improve your recovery and overall health. This study is currently recruiting participants, and it aims to provide valuable insights into how nutrition impacts recovery for patients at risk of malnutrition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Informed Consent as documented by signature
  • Adult (age ≥18 years), medical patients
  • Nutritional risk screening using the Nutritional Risk Screening (NRS): total score ≥3 points consisting of ≥1 points for impairment of the nutritional status \[weight loss \>5% in 3 month or food intake of 50-75% in the last week before hospital admission\] plus ≥1 for the severity of the disease (i.e., cancer, chronic kidney disease, chronic heart failure, COPD) and other chronic diseases according to the definition of the "National Center for Chronic Disease Prevention and Health Promotion": Chronic diseases are defined broadly as conditions that last 1 year or more and require ongoing medical attention or limit activities of daily living or both .
  • Exclusion Criteria:
  • after surgery
  • unable to ingest oral nutrition
  • need for long-term nutrition,
  • terminal condition
  • acute pancreatitis or acute liver failure
  • patients discharged to a nursing home
  • patients unlikely to comply with nutritional support treatment (e.g., dementia)
  • COVID-Hospitalisation requiring intensive care

About Philipp Schuetz

Philipp Schuetz is a distinguished clinical trial sponsor renowned for his commitment to advancing medical research and improving patient outcomes. With a strong background in internal medicine and a focus on innovative therapeutic approaches, Schuetz leads a team dedicated to conducting rigorous clinical trials that adhere to the highest ethical and scientific standards. His expertise spans multiple therapeutic areas, emphasizing the importance of evidence-based practice and collaboration with healthcare professionals. Under his guidance, the organization aims to facilitate the development of cutting-edge treatments while ensuring participant safety and data integrity throughout the research process.

Locations

Valladolid, Spain

Zürich, Switzerland

Getafe, Spain

Münsterlingen, Thurgau, Switzerland

Lachen, Schwyz, Switzerland

Zürich, Switzerland

Málaga, Spain

Sankt Gallen, Switzerland

Aarau, Switzerland

Bern, Switzerland

Lucerne, Switzerland

Zofingen, Aargau, Switzerland

Burgdorf, Bern, Switzerland

Thun, Bern, Switzerland

Zürich, Switzerland

Barcelona, Spain

León, Spain

Madrid, Spain

Patients applied

0 patients applied

Trial Officials

Philipp Schuetz, Prof. Dr. med.

Principal Investigator

Kantonsspital Aarau, University Department of Internal Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials